sb 203580 has been researched along with quercetin in 14 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (quercetin) | Trials (quercetin) | Recent Studies (post-2010) (quercetin) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 12,403 | 239 | 7,510 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caivano, M; Cohen, P; Davies, SP; Reddy, H | 1 |
| McGovern, SL; Shoichet, BK | 1 |
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Ishikawa, Y; Kitamura, M | 1 |
| Koop, DR; Wadsworth, TL | 1 |
| Kanbach, K; Pekrun, A; Roth, C; Schulze, S; Witt, O | 1 |
| Cao, J; Cetrulo, CL; Kandere-Grzybowska, K; Kempuraj, D; Theoharides, TC | 1 |
| Li, L; Li, QJ; Li, WB; Sun, XC; Xian, XH; Yan, CZ; Zhang, M | 1 |
| Chang, YC; Ho, YC; Lee, SS; Tsai, CH; Yu, CC | 1 |
| Du, M; Gao, C; Li, Y; Liu, L; Shi, Y; Tang, Y; Xing, M; Xiong, T; Yao, P | 1 |
| Kim, GT; Kim, JI; Kim, YM; Lee, SH | 1 |
| Ha, KT; Kim, BJ; Kim, MC; Kim, SY; Lee, HJ; Lim, B; So, I | 1 |
| Cho, SK; Jeong, KJ; Kim, S; Park, JW; Park, WJ | 1 |
14 other study(ies) available for sb 203580 and quercetin
| Article | Year |
|---|---|
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetophenones; Alkaloids; Amides; Animals; Benzamides; Benzophenanthridines; Benzopyrans; Butadienes; Cell Line; Enzyme Inhibitors; Flavonoids; Humans; Imidazoles; Indoles; Inhibitory Concentration 50; Isoquinolines; Lithium; Magnesium; Nitriles; Phenanthridines; Phosphorylation; Potassium Chloride; Protein Kinase Inhibitors; Protein Kinases; Pyridines; Sirolimus; Substrate Specificity; Sulfonamides | 2000 |
Kinase inhibitors: not just for kinases anymore.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Biological; Phosphotransferases; Scattering, Radiation | 2003 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
Topics: Animals; Apoptosis; Cells, Cultured; Curcumin; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation, Enzymologic; Glomerular Mesangium; Hydrogen Peroxide; Imidazoles; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Mutagenesis; Oxidants; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Pyridines; Quercetin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription Factor AP-1; Transfection | 2000 |
Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; Ginkgo biloba; Imidazoles; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroprusside; Plant Extracts; Pyridines; Quercetin; Tumor Necrosis Factor-alpha | 2001 |
Tumor cell differentiation by butyrate and environmental stress.
Topics: Butyrates; Cell Differentiation; Enzyme Inhibitors; HL-60 Cells; Hot Temperature; HT29 Cells; Humans; Imidazoles; K562 Cells; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Osmolar Concentration; p38 Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Pyridines; Quercetin; Tumor Cells, Cultured | 2001 |
Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin.
Topics: Carbazoles; Cell Line, Tumor; Cells, Cultured; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Humans; Imidazoles; Indoles; Interleukin-1; Interleukin-6; Isoenzymes; Mast Cells; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Pyridines; Quercetin | 2006 |
Activation of p38 MAPK participates in brain ischemic tolerance induced by limb ischemic preconditioning by up-regulating HSP 70.
Topics: Animals; Blotting, Western; Brain Ischemia; CA1 Region, Hippocampal; Disease Susceptibility; Enzyme Activation; Hindlimb; HSP70 Heat-Shock Proteins; Imidazoles; Immunohistochemistry; Ischemic Preconditioning; Male; p38 Mitogen-Activated Protein Kinases; Pyridines; Quercetin; Rats; Rats, Wistar; Up-Regulation | 2010 |
Heat shock protein 27 expression in areca quid chewing-associated oral squamous cell carcinomas.
Topics: Acetylcysteine; Areca; Arecoline; Carcinoma, Squamous Cell; Case-Control Studies; Catechin; Cyclooxygenase 2 Inhibitors; Down-Regulation; Female; Flavonoids; Gene Expression; Gene Expression Regulation, Neoplastic; HSP27 Heat-Shock Proteins; Humans; Imidazoles; Male; Middle Aged; Mouth Neoplasms; Nitrobenzenes; Pyridines; Quercetin; Sulfonamides | 2012 |
Carbon monoxide alleviates ethanol-induced oxidative damage and inflammatory stress through activating p38 MAPK pathway.
Topics: Alanine Transaminase; Animals; Anthracenes; Aspartate Aminotransferases; Carbon Monoxide; Ethanol; Flavonoids; Glutathione; Heme Oxygenase-1; Hepatocytes; Imidazoles; Interleukin-6; L-Lactate Dehydrogenase; Liver Diseases, Alcoholic; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Organometallic Compounds; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Phytochemicals; Pyridines; Quercetin; Rats; Tumor Necrosis Factor-alpha | 2013 |
Quercetin regulates the sestrin 2-AMPK-p38 MAPK signaling pathway and induces apoptosis by increasing the generation of intracellular ROS in a p53-independent manner.
Topics: Acetylcysteine; AMP-Activated Protein Kinases; Apoptosis; bcl-2-Associated X Protein; Benzothiazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Activation; Humans; Imidazoles; Intracellular Space; MAP Kinase Signaling System; Nuclear Proteins; p38 Mitogen-Activated Protein Kinases; Pyridines; Quercetin; Reactive Oxygen Species; RNA, Small Interfering; Toluene; Transfection; Tumor Suppressor Protein p53 | 2014 |
Quercetin induces apoptosis by inhibiting MAPKs and TRPM7 channels in AGS cells.
Topics: Anthracenes; Apoptosis; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Flavonoids; Humans; Imidazoles; Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Pyridines; Quercetin; TRPM Cation Channels | 2014 |
Caffeic acid, morin hydrate and quercetin partially attenuate sulfur mustard-induced cell death by inhibiting the lipoxygenase pathway.
Topics: Antioxidants; Caffeic Acids; Cell Death; DNA Adducts; Flavonoids; Gene Expression Regulation; Imidazoles; Keratinocytes; Lipoxygenase; Mustard Gas; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Quercetin; Reactive Oxygen Species; Signal Transduction; Tumor Suppressor Protein p53 | 2016 |